KROS: kerostx.com Expected earnings per share growth for next year

Public company logo of Keros Therapeutics (KROS)

Keros Therapeutics (KROS) relies on ESG principles and bioethics in the development of hematological drugs. Expected EPS dynamics for the next period confirm this stability, while -45.00 captures the current value of the indicator. Promising muscle and blood drugs are being prepared for monetization, and strict control over sample transportation ensures the accuracy of clinical trial data.

Keros Therapeutics Inc (KROS): Net earnings per share change forecast for next year from 07/04/2022 to 11/18/2026

Analytical breakdowns and data insights for company Keros Therapeutics Inc (KROS)

- share price and consensus valuation forecast:
Fundamental company valuation:KROS, kerostx.com
Finished products of Keros Therapeutics, Inc.

This indicator measures the expected growth rate of earnings per share, serving as a leading marker of fundamental value amid cost of capital volatility. By correlating the assessment of future EPS dynamics with the flawless operation of biocomplexes and the adherence to experimental batch release deadlines at Keros Therapeutics (KROS), investors can validate the resilience of financial forecasts through actual production efficiency.

Analysis of competing companies

VRTX (Vertex) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ALNY (Alnylam)|Expected earnings per share growth for next year INSM (Insmed)|UTHR (United Therapeutics Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Net earnings per share change forecast for next year|BGM Group Ltd - Earnings growth forecast for next year|Expected earnings per share trend next year COGT (Cogent Biosciences)|XERS: Earnings growth forecast for next year|Arcturus Therapeutics Inc (ARCT) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Eton Pharma|KMDA: Expected earnings per share trend next year|Net earnings per share growth forecast for next year fulcrumtx.com (FULC)|Expected earnings per share growth for next year Abeona Therapeutics Inc. ABEO|Earnings growth forecast for next year MREO (Mereo BioPharma Group)|PLX (Protalix BioTherapeutics Inc.) - Net earnings per share change forecast for next year|PLRX - Net earnings per share growth forecast for next year|APLT - Earnings growth forecast for next year|RNTX: Earnings growth forecast for next year|Expected net earnings per share growth next year Gelteq Limited Inc (GELS)|Expected earnings per share growth for next year AYTU|Expected net earnings per share growth next year chemomab.com CMMB|Expected earnings per share growth for next year SRXH (SRx Health Solutions Inc)|PLRZ - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Expected net earnings per share growth next year|INZY - Net earnings per share growth forecast for next year|Expected earnings per share trend next year RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Net earnings per share growth forecast for next year